Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Multi-platform
100%
Molecular Profiling
100%
Phyllodes Tumor
100%
Metastatic Tumor
60%
PIK3CA
40%
Primary Tumor
40%
Angiogenesis
40%
Genome-wide Expression
40%
Treatment Options
20%
Gene Sequencing
20%
Overexpression
20%
Clinical Trials
20%
Effective Treatment
20%
Pathogenic mutations
20%
Protein Expression
20%
Gene mutation
20%
KRAS mutation
20%
Copy number Analysis
20%
In(III)
20%
Vascular Cell Adhesion molecule-1 (VCAM-1)
20%
Tumor Expression
20%
Novel Targeted Therapy
20%
Programmed Death-ligand 1 (PD-L1)
20%
Vascular Endothelial Growth Factor
20%
Antiangiogenic
20%
Sarcoma
20%
Immunotherapeutic Approaches
20%
Molecular Biomarkers
20%
Gene Copy number
20%
Tumor Protein p53 (TP53)
20%
Expression Analysis
20%
Platelet-derived Growth Factor Receptor (PDGFR)
20%
Gene Overexpression
20%
Anti-EGFR
20%
Immune Checkpoint
20%
Therapy Options
20%
EGFR mutation
20%
Protein Overexpression
20%
Angiopoietin-2
20%
Immunoregulatory Protein
20%
RB1 Gene
20%
PTTG1
20%
EGFRvIII
20%
Rare Breast Malignancies
20%
EGFR Protein
20%
EGFR Gene
20%
Sarcomatous Overgrowth
20%
Medicine and Dentistry
Biological Marker
100%
Epidermal Growth Factor Receptor
100%
Molecular Profiling
100%
Phyllodes Tumor
100%
Metastatic Carcinoma
60%
Primary Tumor
40%
Angiogenesis
40%
Gene Expression
40%
Gene Sequence
20%
Neoplasm
20%
Clinical Trial
20%
Cancer
20%
Targeted Therapy
20%
Gene Mutation
20%
Protein Expression
20%
Programmed Death-Ligand 1
20%
Antiangiogenic
20%
Expression Analysis
20%
Gene Dosage
20%
Angiopoietin 2
20%
Connective Tissue Cancer
20%
Treatment Option
20%
Effective Treatment
20%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Epidermal Growth Factor Receptor
100%
Phyllodes Tumor
100%
Primary Tumor
40%
Neoplasm
20%
Clinical Trial
20%
Antiangiogenic
20%
Angiopoietin 2
20%
Connective Tissue Cancer
20%